Waters Corporation Announces Spin-Off of Biosciences and Diagnostic Solutions Business

Details

The transaction involves the distribution of SpinCo Common Stock to BD's stockholders, followed by a merger where Merger Sub will be merged with and into SpinCo, with SpinCo surviving. In connection with this transaction, Waters has filed a registration statement on Form S-4 and a definitive proxy statement/prospectus, and has provided supplemental disclosures to address concerns about the adequacy of the disclosures made in the proxy statement/prospectus. The filing also includes unlevered free cash flow projections for Waters and the BDS Business and financial multiples for comparable companies.

Items reported

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.